美国经导管二尖瓣缘对缘修复术短期结果的时间趋势:全国代表性研究-53536

基于NRD数据库的TEER手术患者临床表格数据,分析2014-2018年美国二尖瓣反流患者经导管缘对缘修复术的短期预后趋势。

Taylor & FrancisTaylor & Francis
DataCite Commons
2021-05-27 更新
浏览 6
表格in-hospital mortalitystrokereadmissiontrends
Temporal Trends of Transcatheter Edge-to-Edge Repair of the Mitral Valve Short-Term Outcomes in the United States: Nationwide Representative Study

基本信息

模态
表格
大小
0.000099578 GB
许可
CC BY 4.0
创建/更新时间
2021-05-27
版本
v1

资源简介

美国经导管二尖瓣缘对缘修复术短期结果的时间趋势:全国代表性研究

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 5 个文件、合计 99.58 KB,主题涵盖 in-hospital mortality、stroke、readmission、trends,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Temporal Trends of Transcatheter Edge-to-Edge Repair of the Mitral Valve Short-Term Outcomes in the United States: Nationwide Representative Study》。配套论文《Temporal Trends of Transcatheter Edge-to-Edge Repair of the Mitral Valve Short-Term Outcomes in the United States: Nationwide Representative Study》发表于 Structural Heart(2021),DOI:10.1080/24748706.2021.1883204。项目资助方:This work was made possible by a generous gift from Jennifer and Robert McNeil. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and the preparation, review, or approval of the manuscript.。源站首次发布:2021-02-01。

【数据内容】

源站原始描述:Background: Transcatheter edge-to-edge repair of the mitral valve (TEER) has recently emerged as a viable treatment option in high-risk patients with severe mitral regurgitation. The present study investigated the trends in TEER short-term outcomes during 2014–2018. Methods: We performed a retrospective study using the Nationwide Readmissions Database. We analyzed data on the in-hospital and 30-day outcomes of patients who underwent TEER procedure during 2014–2018. Results: A total of 22,914 pat…

【数据结构与技术规格】

文件数 5 个,合计 99.58 KB。ushj_a_1883204_sm6174.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,18.35 KB。ushj_a_1883204_sm6152.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,18.86 KB。ushj_a_1883204_sm6118.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,19.04 KB。数据集 DOI:10.6084/m9.figshare.13682141.v1。

【主题与分类】

源站学科分类:Medicine、Neuroscience、Developmental Biology。主题标签:in-hospital mortality、stroke、readmission、trends。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Temporal_Trends_of_Transcatheter_Edge-to-Edge_Repair_of_the_Mitral_Valve_Short-Term_Outcomes_in_the_United_States_Nationwide_Representative_Study/13682141

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Temporal Trends of Transcatheter Edge-to-Edge Repair of the Mitral Valve Short-Term Outcomes in the United States: Nationwide Representative Study. Taylor & Francis. Abdelfattah, Omar M.; Saad, Anas M.; Hisung, Ingrid; Abushouk, Abdelrahman I.; Gad, Mohamed M.; Okasha, Osama; et al

【使用注意】

· 源站最后修改于 2023-05-31,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "ushj_a_1883204_sm6174.docx" "https://ndownloader.figshare.com/files/26262866"
curl -L -o "ushj_a_1883204_sm6152.docx" "https://ndownloader.figshare.com/files/26262869"
curl -L -o "ushj_a_1883204_sm6118.docx" "https://ndownloader.figshare.com/files/26262872"
curl -L -o "ushj_a_1883204_sm6076.docx" "https://ndownloader.figshare.com/files/26262875"
curl -L -o "ushj_a_1883204_sm6034.jpg" "https://ndownloader.figshare.com/files/26262878"

文件清单

  • ushj_a_1883204_sm6174.docx(18.35 KB)
  • ushj_a_1883204_sm6152.docx(18.86 KB)
  • ushj_a_1883204_sm6118.docx(19.04 KB)
  • ushj_a_1883204_sm6076.docx(18.79 KB)
  • ushj_a_1883204_sm6034.jpg(24.55 KB)

文件总体积 99.58 KB(源站 API 实测)。

数据说明

Background: Transcatheter edge-to-edge repair of the mitral valve (TEER) has recently emerged as a viable treatment option in high-risk patients with severe mitral regurgitation. The present study investigated the trends in TEER short-term outcomes during 2014–2018.
Methods: We performed a retrospective study using the Nationwide Readmissions Database. We analyzed data on the in-hospital and 30-day outcomes of patients who underwent TEER procedure during 2014–2018.
Results: A total of 22,914 patients underwent TEER; 1,674 in 2014, 3,252 in 2015, 4,645 in 2016, 6,000 in 2017, and 7,343 in 2018 with a median age of 78, 80, 81, and 80 years, respectively, with a 4.2 fold increase in TEER utilization. Heart failure was present in 75.6%, and 83.6% of patients, in 2014, and 2018 respectively, while 73.3%, and 85.3% of patients, respectively, had hypertension. In-hospital mortality following TEER was significantly decreased from 3.9% in 2014 to 2% in 2018 (P P = 0.093), and the median length of hospital stay was significantly shortened from 4 to 2 days (P P = 0.876); however, the 30-day HF readmission rate exhibited a significant decline from 4.7% in 2014 to 0.6% in 2018 (P Conclusion: Although TEER therapy is now offered to a more critically ill and larger patient population in the United States, the outcomes of patients undergoing TEER are improving with decreasing mortality, morbidity, and hospital stay.
Abbreviations: TEER: Transcatheter edge-to-edge repair of the mitral valve (TEER); NRD: National Readmissions Database; MR: Mitral Regurgitation; DMR: Degenerative Mitral Regurgitation; FMR: Functional Mitral Regurgitation; HF: Heart failure; LVEF: Left Ventricular Ejection Fraction; GDMT: Guideline-Directed Management and Therapy; AKI: Acute Kidney Injury; MI: Myocardial infarction

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.13682141.v1(source: https://tandf.figshare.com/articles/dataset/Temporal_Trends_of_Transcatheter_Edge-to-Edge_Repair_of_the_Mitral_Valve_Short-Term_Outcomes_in_the_United_States_Nationwide_Representative_Study/13682141)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案